PetMed Express, Inc. (NASDAQ:PETS) will unveil its latest earnings on Monday, July 18, 2011. PetMed Express is a nationwide pet pharmacy. The Company markets prescription and non-prescription pet medications and other health products for dogs, cats, and horses direct to the consumer.
PetMed Express, Inc. Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average estimate of analysts is for profit of 24 cents per share, a decline of 25% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from 30 cents. Between one and three months ago, the average estimate moved down and dropped from 25 cents during the last month. For the year, analysts are projecting net income of 77 cents per share, a decline of 16.3% from last year.
Past Earnings Performance: The company fell short of estimates last quarter after being in line with forecasts the quarter prior. In the fourth quarter of the last fiscal year, it reported profit of 19 cents per share versus a mean estimate of 22 cents. Two quarters ago, it reported net income of 20 cents per share.
Wall St. Revenue Expectations: On average, analysts predict $74.1 million in revenue this quarter, a decline of 0.3% from the year ago quarter. Analysts are forecasting total revenue of $233 million for the year, a rise of 0.6% from last year’s revenue of $231.6 million.
Analyst Ratings: Analysts are bearish on PetMed Express as four analysts rate it as a sell, two rate it as a buy and two rate it as a hold.
A year-over-year revenue increase in the fourth quarter of the last fiscal year snaps a streak of three consecutive quarters of revenue declines. Revenue rose 1.2% in the fourth quarter of the last fiscal year and fell 6.7% in the third quarter of the last fiscal year, 1.9% in the second quarter of the last fiscal year and 3.6% in the first quarter of the last fiscal year.
Competitors to Watch: Rite Aid Corporation (NYSE:RAD), Walgreen Company (NYSE:WAG), drugstore.com, inc. (NASDAQ:DSCM), China Nepstar Chain Drugstore Ltd. (NYSE:NPD), Graymark Healthcare Inc (NASDAQ:GRMH), CVS Caremark Corporation (NYSE:CVS), Wal-Mart (NYSE:WMT) and Target (NYSE:TGT).
Stock Price Performance: During April 14, 2011 to July 12, 2011, the stock price had fallen $2.66 (-18.1%) from $14.67 to $12.01. The stock price saw one of its best stretches over the last year between October 13, 2010, and October 21, 2010, when shares rose for seven-straight days, rising 7.5% (+$1.13) over that span. Shares have been on a negative streak of late, closing down every day between July 11, 2011 and July 12, 2011. Shares are down $5.49 (-31.4%) year to date.
(Source: Xignite Financials)
Get Actionable Investing Insights: Check Out Wall St. Cheat Sheet’s newest Feature Trades of the Month!